Kliničke preporuke Hrvatskog društva za internističku onkologiju HLZ-a
2. dio: rak bubrega, rak mokraćnog mjehura, rak prostate, rak testisa
Gnjidić M, Vojnović Ž, Čonkaš M i sur. Liječ Vjesn 2016; 138: 167-72.
Praćenje onkoloških bolesnika 2. dio
Praćenje onkoloških bolesnika: rak bubrega, rak mokraćnog mjehura, rak prostate, rak testisa
ESMO RSS- FDA Approves Revumenib for Relapsed or Refractory Acute Myeloid Leukaemia with a Susceptible NPM1 Mutation 30. listopada 2025.
- Antitumour Activity of Patritumab Deruxtecan in Heavily Pretreated Patients with Active Brain Metastases of Breast Cancer and NSCLC 29. listopada 2025.
- EMA Recommends Extension of Indications for Sugemalimab 28. listopada 2025.
- Marking Breast Cancer Awareness Month 2025, ESMO Calls for Increasing Awareness of the Cancer Risks Posed by Alcohol & the Development of Robust Policy Measures to Prevent Breast Cancer Cases 27. listopada 2025.
